MedTrace Logo

Behavioral Studies and Practices

NCT03685292 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2018-09-26

No results posted yet for this study

Summary

The focus of this study is to evaluate whether a new fraud material will be suitable for a technological device and or software. \*\*\*For consultation purposes only.\*\*\*

Conditions

  • Behavioral

Interventions

BEHAVIORAL

Behavioral Advisory System

Support and training to help increase throughput while promoting upstanding stature and reproducibility in behavioral testing using cutting edge methodologies.

DRUG

Behavioral Treatment

This study addressed the efficacy of cognitive-behavioral therapy (CBT) treatment.

DEVICE

Behavioral Division

This study is relative to minimal contact control (MCC).

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Brian Bolden

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2018-04-30
Completion
2018-05-12
FDA Drug
Yes
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03685292 on ClinicalTrials.gov